Market Currents
Cepheid (CPHD +3.8%) moves up today after the company received FDA clearance for its Xpert CT/NG...
-
Friday, December 28, 2012, 12:26 PM ETCepheid (CPHD +3.8%) moves up today after the company received FDA clearance for its Xpert CT/NG diagnostic test, for the rapid detection and differentiation of Chlamydia trachomatis and Neisseria gonorrhoeae.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
